at-home testing
Consumers can use the tests to detect Lyme disease, vitamin D levels, thyroid function and sexually transmitted infections.
The system delivers its results to a companion app in about 20 minutes, according to the agency.
The company is initially targeting the large employer market with its app-connected biometric monitoring tools.
The company projects that sales of its testing kits will triple by the end of 2020.
Lucira's molecular testing kit allows individuals to collect their own nasal sample and insert it into a device that provides results in under 30 minutes. The company is aiming to sell the single-use tests for roughly $50.
This news comes just months after it closed its $25 million Series B round.
The companies are reported to have agreed on a $9 million deal with milestones for Inui Health (formerly known as Scanadu).
The Cue Health Monitoring System can deliver its results through a smartphone dashboard, and is intended for use by health professionals and consumers alike.
The startup, which specializes in a range of at-home testing kits, so far only offers a COVID-19 testing product for point-of-care providers.
Using a designated kit ordered by a doctor, patients will be able to self-swab and mail their samples to LabCorp testing facilities. The self-collection kits will be available in "most states" in the coming weeks.